Moscow State University

Dr. Kristina Shampanier Joins BRG's Economics & Damages Community

Retrieved on: 
Wednesday, March 20, 2024
Consumer, Research, Controversy, New Economic School, Berkeley Research Group, BRG, Intellectual property, Patent, Marketing, Economics, Moscow State University

CHICAGO, March 20, 2024 /PRNewswire/ -- Global expert services and consulting firm Berkeley Research Group (BRG) announced today that Dr. Kristina Shampanier has joined its Economics, Disputes & Investigations business line as a managing director in Los Angeles.

Key Points: 
  • CHICAGO, March 20, 2024 /PRNewswire/ -- Global expert services and consulting firm Berkeley Research Group (BRG) announced today that Dr. Kristina Shampanier has joined its Economics, Disputes & Investigations business line as a managing director in Los Angeles.
  • She has worked on class action, false advertisement, product defect, trademark, trade dress and patent infringement cases, as well as antitrust and healthcare matters.
  • "Kristina's advanced understanding of marketing research and economics enables the top-level research that today's high-stakes class actions demand," said Jeffery Stec , a BRG managing director, leader of BRG's Intellectual Property practice and co-leader of its Economics & Damages community.
  • "With deep trademark, class action and damages experience, BRG provides an excellent platform for my practice," said Dr. Shampanier.

Triterras Announces the Addition of Two New Hires to Serve a Growing Pipeline of Funding Opportunities

Retrieved on: 
Tuesday, September 26, 2023
Business development, Risk, BTA Bank, Moscow State University, Financial services, Head, Credit Europe Bank, HSBC Bank Middle East, Business, Nordea, MENAT, Guidepoint, Business administration, AVP, Distribution, Master, CISI, Security (finance), Chartered Institute for Securities & Investment, KYC, Drug, Cryptocurrency

Marina Golubeva and Ali Rakib will engage with institutional investors who are interested in deploying capital for cross-border trade finance opportunities.

Key Points: 
  • Marina Golubeva and Ali Rakib will engage with institutional investors who are interested in deploying capital for cross-border trade finance opportunities.
  • Prior to Triterras, Ms. Golubeva worked in trade and structured finance for BTA Bank, Nordea Bank and Credit Europe Bank.
  • He is based in Dubai and will be growing Triterras’ network of institutional investors from the Emirates, Europe and beyond.
  • I am delighted to welcome them both as Triterras continues to deepen our bench for origination-to-distribution capabilities and serve a growing pipeline of trade and supply chain finance lending opportunities,” said Srinivas Koneru, Chairman and CEO at Triterras.

Liaocheng, China holds cultural exchange activity for Russian youth students

Retrieved on: 
Thursday, May 25, 2023
Beauty, Culture, Institute of technology, University, Russian Presidential Academy of National Economy and Public Administration, Moscow State University, Liaocheng University, Research, National economy, Student, Economic and Technology Cooperation Agreement, Bauman Moscow State Technical University, Tourism

LIAOCHENG, China, May 25, 2023 /PRNewswire/ -- This is a report from the Shandong office of the Hong Kong Business Daily.

Key Points: 
  • LIAOCHENG, China, May 25, 2023 /PRNewswire/ -- This is a report from the Shandong office of the Hong Kong Business Daily.
  • From May 1st to 7th, the 2023 Russian Youth Student Visiting Group, jointly organized by the Russia-China Association for the Promotion of Cultural, Scientific and Technological Cooperation and Liaocheng University, paid a visit to Liaocheng, China, and carried out the cultural exchange and experience activity of "Visiting the Millennium Canal and enjoying the Beauty of Chinese Language".
  • They also participated the Chinese and foreign youth roundtable, sharing stories of youth fighting for a better future.
  • Liaocheng University will actively carry out research, projects, and activities on cultural exchanges between Chinese and foreign youth so as to enhance their cultural literacy, promote friendly exchanges between Chinese and foreign youth, and enhance the international development level of the university.

Quant Millburn Hires Irina Bogacheva as Director of Research

Retrieved on: 
Wednesday, March 1, 2023
Data Analytics, Asset Management, Professional Services, Finance, Legg Mason, Columbia University, Moscow State University, University, New Economic School, DWS Group, Doctor of Philosophy, Bogachyov, QS, Om, Goldman Sachs, David G. Booth, Research, Investment, Management, Economics, Mathematics

Millburn Ridgefield Corporation (“Millburn”), the multi-billion AuM quantitative investment firm based in New York, is pleased to announce the addition of Irina Bogacheva as director of research, effective February 27, 2023.

Key Points: 
  • Millburn Ridgefield Corporation (“Millburn”), the multi-billion AuM quantitative investment firm based in New York, is pleased to announce the addition of Irina Bogacheva as director of research, effective February 27, 2023.
  • Bogacheva will report to Michael Soss, deputy chief investment officer, who joined Millburn in early 2022 from Point72 Asset Management.
  • I am looking forward to working with this talented team on expanding the firm’s systematic capabilities,” says Bogacheva.
  • As director of research, Bogacheva will focus on the continuing refinement and broadening of Millburn’s successful systematic research and development functions, including portfolio, modelling, and predictive frameworks and processes.

CHARM Therapeutics Strengthens Leadership Team with Key Appointments to Support Drug Discovery and Development Capability

Retrieved on: 
Wednesday, January 4, 2023
Biomedicine, Hoffmann-La Roche, Khosla Ventures, Stanford University, D, Machine learning, Roivant Sciences, Agios Pharmaceuticals, Pfizer, Doctor of Philosophy, Drug discovery, Head, Research, General Catalyst, Publication, Biology, Master of Science, Medicine, The Tumor, University of Minnesota College of Food, Agricultural and Natural Resource Sciences, Intelligence, AMAG Pharmaceuticals, ARIAD Pharmaceuticals, 3D, Therapy, Drug development, Vertex, Deep learning, GSK, Toxicology, University, Family, Cancer Research UK, Cell, Senior, Weill Cornell Graduate School of Medical Sciences, Pharmacokinetics, Merck & Co., MBA, Data management, Moscow State University, Immersion, DPU, Medical device, Pharmaceutical industry, Management, Crystallography, Science, Health care, Economics, Pharmacology, AI, Nature

LONDON – 4 January 2023 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research Company discovering and developing transformational medicines, today announces the expansion of its leadership team with a series of key appointments to strengthen its drug discovery and development, as well as operational management capabilities.

Key Points: 
  • Enhanced leadership team brings strong AI and drug discovery expertise and experience, reinforcing CHARM Therapeutics’ existing R&D capabilities
    LONDON – 4 January 2023 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research Company discovering and developing transformational medicines, today announces the expansion of its leadership team with a series of key appointments to strengthen its drug discovery and development, as well as operational management capabilities.
  • These appointments will support CHARM as it builds out of its research and development function to advance discoveries driven by its proprietary 3D deep-learning engine towards development.
  • CHARM Therapeutics raised $50 million in a Series A financing round announced in 2022, led by F-Prime Capital and OrbiMed, with General Catalyst and Khosla Ventures.
  • Gary D. Glick Ph.D., Executive Chair of CHARM Therapeutics, commented: “The exceptional people joining CHARM bring the perfect combination of skills, from immersion in AI, oncology and translational research to long experience in organizational leadership.

JDRF T1D Fund, Leading Disease-Focused Venture Philanthropy Fund, Elevates Yury Kukushkin to Managing Director

Retrieved on: 
Wednesday, September 7, 2022
Diabetes, Other Health, Health, Foundation, Philanthropy, Partnership, RNA, Research, Therapy, Virology, Board, Fund, JDRF, Investment, Moscow State University, Foundation, T1D, Proteolysis targeting chimera, Specialization, Pharmaceutical industry, Biochemistry

The JDRF T1D Fund (T1D Fund or the Fund), a venture philanthropy fund focused on curing type 1 diabetes (T1D), today announced the promotion of Yury Kukushkin to Managing Director.

Key Points: 
  • The JDRF T1D Fund (T1D Fund or the Fund), a venture philanthropy fund focused on curing type 1 diabetes (T1D), today announced the promotion of Yury Kukushkin to Managing Director.
  • In his expanded role, Dr. Kukushkin will lead new investments as well as continue to support the T1D Funds large and diverse set of existing investments.
  • Dr. Kukushkin has a decade of life sciences investment experience, and since joining the T1D Fund in 2019, he has played a critical role in expanding the T1D Funds investment activities into a variety of biologics, cell therapy, and gene therapy companies.
  • The T1D Fund invests in areas strategically aligned with JDRF, the leading global organization funding T1D research, with an exclusive focus on supporting the best commercial opportunities.

EdTech Unicorn EEO Joins Hands with Peking University -- Redesigning learning experiences for the new digital-forward model of education

Retrieved on: 
Friday, July 8, 2022
University of Granada, Research, Adoption, Student, Economics, Mark (given name), Peking University, Education, Cairo University, Partnership, University of Tokyo, Ritsumeikan University, Waseda University, Technology, University, LMS, Chulalongkorn University, Learning, Moscow State University, Cornell University, Osaka University, EEO, Nanyang Technological University, Creativity, Multimedia, Medicine, Tutoring

EEO was founded in 2014 with the purpose of building an inclusive and student-centered learning ecosystem through the power of technology.Since 2019, EEO and Peking University joined hands to collaborate on digitizing physical learning environments, constructing specialized archeology classrooms, and adopting hybrid learning methods.

Key Points: 
  • EEO was founded in 2014 with the purpose of building an inclusive and student-centered learning ecosystem through the power of technology.Since 2019, EEO and Peking University joined hands to collaborate on digitizing physical learning environments, constructing specialized archeology classrooms, and adopting hybrid learning methods.
  • It is a nonstop journey for EEO and Peking University to explore how to better motivate students and support educators in experimental teaching strategies.
  • The project of Global Open Courses Program focuses on how hybrid learning gives rise to an enriched learning experience and expands learning communities.
  • Hybrid learning, a method that incorporates hybrid technologies and open educational practices, has witnessed increasing adoption in K12 and higher ed institutions globally.

ROSNEFT OIL COMPANY: Rosneft Holds Annual General Meeting of Shareholders

Retrieved on: 
Friday, July 1, 2022
Oil, Annual report, Board of directors, Moscow School of Painting, Sculpture and Architecture, MAR, Government, Independent, Company, Republic, Krasnoyarsk Krai, Financial Oversight and Management Board for Puerto Rico, Russia, IFRS, Philippines, MSE, Financial statement, Moscow State University, The Meeting, Federal, Board, Saint Petersburg Mining University, Joint-stock company, Holding company, Management, Rosneft, Economics, EU

Rosneft holds Annual General Meeting of Shareholders.

Key Points: 
  • Rosneft holds Annual General Meeting of Shareholders.
  • The Meeting approved the Annual Report and Financial Statements of Rosneft for 2021.
  • The Company's shareholders also made a decision to approve the recommendations of Rosneft's Board of Directors for the record high dividends.
  • We assume no obligation to adjust the data contained herein to reflect actual results, changes in underlying assumptions or factors affecting the forward-looking statements.

VK Company: VK's Board of Directors Strengthened by Scientific Community Members

Retrieved on: 
Friday, April 1, 2022
Company, Russian Venture Company, Executive, Central Institutional Organization Commission, Bauman Moscow State Technical University, Business, Board, Institute of technology, MAR, Samara National Research University, Research, School, Far Eastern Federal University, Sibur, CEO, Board of directors, Senior, Petropavlovsk plc, Director, Baranov Central Institute of Aviation Motor Development, Machine learning, Investment, LSE, Moscow Polytechnic University, MOEX, VK, Moscow State University, Management, Economics, EU

VK Company Limited (LSE, MOEX: VKCO, hereinafter referred as "VK" or "the Company") announces changes to the Board of Directors.

Key Points: 
  • VK Company Limited (LSE, MOEX: VKCO, hereinafter referred as "VK" or "the Company") announces changes to the Board of Directors.
  • The Company's Board of Directors has been strengthened by the heads of two major Russian universities.
  • In addition, two of VK's senior executives joined the Board of Directors.
  • Alexander Ayvazov (Executive Director), Senior Vice President for Investments and Business Development at VK, oversees the Company's M&A deals and the online education segment.

Contraline Appoints Medical Device Industry Leader Dr. Yelena Tropsha as Chief Technology Officer

Retrieved on: 
Wednesday, March 30, 2022
Medical Devices, Health, Consumer, Other Health, Clinical Trials, Men, Birth, BD (company), Polymer, Clinical trial, Multimedia, Reproductive health, Urology, Doctor of Philosophy, Medtronic, Publication, Man, Entrepreneurship, Gynaecology, Polymer science, Science, Hydrogel, Moscow State University, Birth control, Medical device, Neuronetics, Chemistry

Contraline, Inc. , a venture-backed medical device company devoted to providing men with long-lasting, safe, and effective contraception has appointed medical device industry leader Dr. Yelena Tropsha to the role of Chief Technology Officer.

Key Points: 
  • Contraline, Inc. , a venture-backed medical device company devoted to providing men with long-lasting, safe, and effective contraception has appointed medical device industry leader Dr. Yelena Tropsha to the role of Chief Technology Officer.
  • View the full release here: https://www.businesswire.com/news/home/20220330005043/en/
    Dr. Yelena Tropsha joins Contraline as Chief Technology Officer (Photo: Business Wire)
    Dr. Tropsha brings to Contraline over 25 years of medical device experience, from front-end innovation to commercialization.
  • Dr. Tropsha also held Vice Presidential positions with leading medical device companies DYSIS Medical and Neuronetics and senior technical positions at Medtronic and Becton Dickinson.
  • Contraline, Inc. is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception.